Showing results (1431-1440 of 1,484) with videos related to
Sort By:
Pageof 149
NPJ Breast Cancer|August 16, 2022
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancerJohan Staaf, Jari Häkkinen, Cecilia Hegardt, et al.Pain|February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent painBaoXi Gao, Markus Hierl, Kristie Clarkin, et al.Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channelRoine I Olsson, Ingemar Jacobson, Tommy Iliefski, et al.The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.Journal of Medicinal Chemistry|June 4, 2011
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent painHoward Bregman, Loren Berry, John L Buchanan, et al.American Heart Journal|April 2, 2021
A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocolTuomas Kiviniemi, Juan Bustamante-Munguira, Christian Olsson, et al.BMJ Open|November 29, 2019
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)Usha Menon, Peter Vedsted, Alina Zalounina Falborg, et al.RSC Medicinal Chemistry|July 14, 2025
Topical BET PROTACs for locally restricted protein degradation in the lungMartin Hemmerling, Jianming Liu, Antonio Piras, et al.Haematologica|December 9, 2017
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemiaEdith Schneider, Anna Staffas, Linda Röhner, et al.Pageof 149